🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to verify the efficacy of ASP015K versus pl...
Status
Completed
Location
JP00037
Start Date
2014-07-25
Trial ID
NCT02305849
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01248780
Treatments Being Tested
The study is conducted in order to find out if repeated doses of the monocl...
Status
Completed
Location
Study Site
Start Date
2010-12
Trial ID
NCT01481493
This prospective, within subject clinical trial aims to evaluate the effica...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-01
Trial ID
NCT06877455
Treatments Being Tested
The goal of the present study is to evaluate if addition of methotrexate ca...
Status
Completed
Location
The E. Wolfson.Medical Center
Start Date
2015-07
Trial ID
NCT02269358
Treatments Being Tested
Objectives: A. Primary objective: 1 To assess the feasibility and the eff...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09-12
Trial ID
NCT00866749
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
This retrospective study aims to assess the effectiveness of systemic treat...
Status
Completed
Location
Erasmus MC
Start Date
2022-09-23
Trial ID
NCT06512766
Treatments Being Tested
This is a phase II open label trial designed to evaluate the efficacy of Ta...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2014-12
Trial ID
NCT02206035
Treatments Being Tested
This randomized clinical trial studies standard GVHD prophylaxis with tacro...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2014-07-07
Trial ID
NCT01951885
Treatments Being Tested